Procter and Gamble Hygiene and Health Care
BSE: 500459 | NSE: PGHH | ISIN: INE179A01014 | Personal Care
- Directors Report
- Chairman's Speech
- Auditors Report
- Notes To Accounts
- Accounting Policy
- Finished Products
- Raw Materials
| Directors Report | Year End : Jun '08 |
The Directors have the pleasure of presenting the 44th Annual Report
and the Audited Accounts of the Company for the year ended June 30,
2008.
FINANCIAL RESULTS
(Figures in Rs. Crores)
2007/8 2006/7
Sales (less excise duty) 643.0 538.3
Profit before tax 180.6 145.5
Profit after tax 131.4 89.8
Proposed Dividend plus
tax thereon 76.0 76.0
Transfer to General Reserve 13.15 9.0
Balance carried forward 126.0 83.7
BUSINESS PERFORMANCE
The Company posted excellent business results for the year ended June
30, 2008. The Health Care and Feminine Hygiene business sales at Rs.643
crores (Rs.538.3 crores last year) grew by a healthy 19%. This strong
double-digit growth was driven by focusing on the fundamentals, namely,
strong consumer meaningful innovation backed by distribution growth and
strong advertising support.
The VICKS range of products has shown a robust growth with VICKS
Vaporub and VICKS Cough Drops growing by over 25%. Feminine Hygiene
business too recorded a 21% growth in sales. WHISPER continued to
build trials through novel 6 direct marketing and Point of Market Entry
programs.
Profit Before Tax (PBT) at Rs. 180.6 crores is up by 24% (vs. last
year’s Rs. 145.5 crores). However, the PBT of the last year included
one-time pre- operational expenses on setting up of the Plant. Hence,
PBT, when compared with last year’s PBT excluding these exceptional
expenses, grew by 17%.
During the year under review, your Company delivered a Profit after Tax
(PAT) of Rs.131.4 crores. However, PAT at Rs. 131.4 crores is not
comparable to PAT of Rs.89.8 crores last year. The PAT of last year
includes adjustment for the impact of provisions of taxes for prior
years and for pre-operational expenses on setting up of plants at
Baddi. Even after including the expenses on the aforesaid exceptional
items, PAT is up by 23% primarily reflecting savings from Baddi
tax-free zone, where your Company has set up its health care plant.
Your Company continued with the expansion of capacities for manufacture
of Feminine Hygiene products at its Goa Plant with a capital outlay of
Rs.10 crores during the year. Similarly, the Company made a further
capital investment of Rs.26.7 crores in its two manufacturing sites at
Baddi.
Health Care Business
Health Care sales at Rs. 312.3 crores (vs. last year’s Rs. 268.7
crores) posted a high growth of 16% this year. This growth was
broadbased and came on the back of strong performances by VICKS
Vaporub, VICKS Cough Drops and VICKS Inhaler.
VICKS Vaporub’s impressive growth of 25% was driven by strong equity
advertising to help better connect with consumers. In the case of
Vaporub, a new consumer insight based campaign ‘The Blanket of Warmth’
was introduced to drive trial and consumption. Consumers responded
favorably and we reached a milestone market share for the first time.
The VICKS Cough Drops business made a strong comeback after last year’s
decline, to post a record growth of 27%. The brand also saw its highest
ever sales this year. The cold tablets category witnessed intense
competitive activity this year, due to which sales of VICKS Action 500+
suffered slightly. With the right blend of product innovation and
strong marketing plans, VICKS will continue to develop propositions to
best meet consumer needs and be the preferred brand for cough and cold
care in India.
Feminine Hygiene Business
Feminine Hygiene business recorded another year of high growth with
sales at Rs. 340 crores (vs. Rs. 282 crores last year) translating to
a record 21% growth and value share leadership. This is the fifth year
in succession where WHISPER has grown at such a fast pace.
A number of initiatives were designed to win with the WHISPER Consumer.
All of these initiatives viz. consumer need-based product upgrade on
WHISPER Maxi, value correction on WHISPER Choice, clutter breaking
window display at the retail level, engaging advertising, came together
to take Whisper to a 50% value market share in urban India for the
first time.
WHISPER continued to build future business with an increased focus on
consumers at the Point of Market Entry (POME) stage i.e. when girls
start menstruation. Whisper has quadrupled the number of school girls
contacted and sampled versus two years ago. During the year, your
Company significantly stepped up POME marketing by increasing its reach
by a whopping 40% versus a year ago. Not only did the number of
adolescent girls contacted through this program increase significantly,
but the program reached out to the lower class towns by training the
teachers, to conduct this program at schools. Further the proposition
being offered at these programs has been tailored to suit the
consumers’ need. For example, your Company is offering a mid-tier brand
WHISPER Choice as a sample in Government Schools so that they
experience great performance at a great value.
Being true to your Company’s philosophy of ‘Touching lives, improving
life’, Directors are happy to report that, WHISPER on a pilot basis has
entered into a Public Private Partnership (PPP) with the National Rural
Health Mission (NRHM), Rajasthan, to provide education and sanitary
protection to rural women of Rajasthan to help them lead healthier,
hygienic and more productive lives.
DIVIDEND
Directors are pleased to recommend a dividend of Rs. 20 for each equity
share for the financial year ended June 30, 2008.
CORPORATE SOCIAL RESPONSIBILITY
Shiksha: Padhega India, Badhega India
According to our partner CRY, over 200 million children in India lack
the access to education. Close to 47% of India’s habitation does not
have a primary school. When it comes to children’s education – there is
no dearth of rather disappointing statistics. Program Shiksha is P&G’s
attempt to help address these issues and work towards its vision of
seeing every child in school. Singing the motto ‘Padhega India. Badhega
India’, Shiksha truly believes that the secret to a brighter future of
this country lies in quality education for our children.
Over the last four years Shiksha has been able to lead 87,000 children
on the path of education with all P&G India group Companies donating
over Rs. 8 crores reaching out to over 300 communities. This year’s
contribution of approx. Rs. 3 crores has been the single largest
contribution from P&G India in any year. This year was also memorable
for unique executions like the Shiksha Time Capsule. A school bag full
of items from present day education system was buried deep inside the
earth to be opened 100 years later as a reminder of our times. Actress
Esha Deol attended the ceremony and the program got wide media
coverage.
Each year Shiksha wins the hearts of not just the lives it touches –
but also of everyone that chooses to participate in it. Over the years
we have had over 20 top celebrities from across the country
volunteering their time to help generate awareness of the cause. Our
biggest victory however remains the millions of consumers that believe
in Shiksha and step forward to buy our brands in order to help lead
children towards education in their own little way. It may be just
another drop in the ocean but it is one step closer to a brighter
India.
RESPONSIBILITY STATEMENT
Pursuant to the requirement under section 217(2AA) of the Companies
Act, 1956, with respect to Directors’ Responsibilities Statement, it is
hereby confirmed:
(i) that in the preparation of the annual accounts for the financial
year ended June 30, 2008, the applicable accounting standards had been
followed along with proper explanation relating to material departures;
(ii) that the Directors had selected such accounting policies and
applied them consistently and made judgments and estimates that were
reasonable and prudent so as to give a true and fair view of the state
of affairs of the Company at the end of the financial year and of the
profit or loss of the Company for the year under review;
(iii) that the Directors had taken proper and sufficient care for the
maintenance of adequate accounting records in accordance with the
provisions of the Companies Act, 1956, for safeguarding the assets of
the Company and for preventing and detecting fraud and other
irregularities.
(iv) that the Directors had prepared the accounts for the financial
year ended June 30, 2008, on a “going concern” basis.
CORPORATE GOVERNANCE
A separate report on Corporate Governance along with Auditors’
Certificate on its compliance is annexed to this Report.
MANAGEMENT & PERSONNEL
Directors reiterate their confidence in the valuable contributions of
employees which makes it possible for the Company to maintain the
strong growth despite challenges of competition and for which the
Directors wish to record their sincere appreciation.
The information as per Section 217(2A) of the Companies Act, 1956
(‘Act’), read with the Companies (Particulars of Employees) Rules 1975
forms part of this Report. As per the provisions of Section
219(1)(b)(iv) of the Act, the Report and Accounts are being sent to the
shareholders of the Company excluding the statement of particulars of
employees under Section 217(2A) of the Act. Any shareholder interested
in obtaining a copy of the said statement may write to the Company
Secretary at the Registered Office of the Company.
DIRECTORS
Mr. B. V. Patel, Chairman and Ms. Deborah Henretta, Director, retire by
rotation and, being eligible, offer themselves for re-appointment.
Directors recommend their appointment.
AUDITORS
The Auditors, M/s. Deloitte Haskins & Sells, Mumbai, retire and offer
themselves for re- appointment.
COST AUDITORS
Company has received the approval of the Central Government for
appointment of M/s. P.M. Nanabhoy & Company, Cost Accountants, to
conduct the cost audit of drug formulations for the year ended June 30,
2008. Company has re-appointed M/s. P.M. Nanabhoy & Company as Cost
Auditors for the year ending June 30, 2009, subject to the approval of
the Central Government.
CONSERVATION OF ENERGY ETC. INFORMATION
The information, in accordance with the provisions of Section 217(i)(e)
of the Companies Act, 1956, read with the Companies (Disclosure of
Particulars in the Report of Board of Directors) Rules, 1988, regarding
conservation of energy, technology absorption and foreign exchange
earnings and outgoings, forms part of this Report.
TRADE RELATIONS
Directors wish to thank our Retailers, Wholesalers, Distributors,
Suppliers of Goods & Services, Clearing and Forwarding Agents and all
other business associates and acknowledge their efficiency and
continued support in promoting such healthy growth in the Company’s
business.
ACKNOWLEDGEMENT
Once again our thanks are due to The Procter & Gamble Company USA and
Procter & Gamble International Operation Pte. Limited for the
invaluable support provided by them in terms of access to the latest
information/knowledge in the field of Research & Development for
products, ingredients and technologies; timely inputs to exceptional
marketing strategies; and the goodwill of its world-renowned Trademarks
and superior brands. These have vastly benefitted the Company.
On behalf of the Board of Directors
Mumbai Bharat V. Patel
August 29, 2008 Chairman
|
|
![]() | |
| Source : Religare Technova | |
![]() | |




Online


